For research use only. Not for therapeutic Use.
Navocaftor (GLPG 3067), as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1)[1].
Navocaftor, as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator[1].
| Catalog Number | I033058 |
| CAS Number | 2159103-66-7 |
| Synonyms | [5-[3-amino-5-[4-(trifluoromethoxy)phenyl]sulfonylpyridin-2-yl]-1,3,4-oxadiazol-2-yl]methanol |
| Molecular Formula | C15H11F3N4O5S |
| Purity | ≥95% |
| InChI | InChI=1S/C15H11F3N4O5S/c16-15(17,18)27-8-1-3-9(4-2-8)28(24,25)10-5-11(19)13(20-6-10)14-22-21-12(7-23)26-14/h1-6,23H,7,19H2 |
| InChIKey | WOXOLLSAICIZNO-UHFFFAOYSA-N |
| SMILES | C1=CC(=CC=C1OC(F)(F)F)S(=O)(=O)C2=CC(=C(N=C2)C3=NN=C(O3)CO)N |
| Reference | [1]. US 20200377491 Al |
